IBDEI0UX ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14228,1,4,0)
 ;;=4^H25.13
 ;;^UTILITY(U,$J,358.3,14228,2)
 ;;=^5005286
 ;;^UTILITY(U,$J,358.3,14229,0)
 ;;=H25.12^^82^775^11
 ;;^UTILITY(U,$J,358.3,14229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14229,1,3,0)
 ;;=3^Cataract,Age-Related Nuclear,Left Eye
 ;;^UTILITY(U,$J,358.3,14229,1,4,0)
 ;;=4^H25.12
 ;;^UTILITY(U,$J,358.3,14229,2)
 ;;=^5005285
 ;;^UTILITY(U,$J,358.3,14230,0)
 ;;=H25.11^^82^775^12
 ;;^UTILITY(U,$J,358.3,14230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14230,1,3,0)
 ;;=3^Cataract,Age-Related Nuclear,Right Eye
 ;;^UTILITY(U,$J,358.3,14230,1,4,0)
 ;;=4^H25.11
 ;;^UTILITY(U,$J,358.3,14230,2)
 ;;=^5005284
 ;;^UTILITY(U,$J,358.3,14231,0)
 ;;=G45.3^^82^775^1
 ;;^UTILITY(U,$J,358.3,14231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14231,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,14231,1,4,0)
 ;;=4^G45.3
 ;;^UTILITY(U,$J,358.3,14231,2)
 ;;=^304129
 ;;^UTILITY(U,$J,358.3,14232,0)
 ;;=D31.32^^82^775^16
 ;;^UTILITY(U,$J,358.3,14232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14232,1,3,0)
 ;;=3^Choroidal Nevus,Left Eye
 ;;^UTILITY(U,$J,358.3,14232,1,4,0)
 ;;=4^D31.32
 ;;^UTILITY(U,$J,358.3,14232,2)
 ;;=^5002122
 ;;^UTILITY(U,$J,358.3,14233,0)
 ;;=D31.31^^82^775^17
 ;;^UTILITY(U,$J,358.3,14233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14233,1,3,0)
 ;;=3^Choroidal Nevus,Right Eye
 ;;^UTILITY(U,$J,358.3,14233,1,4,0)
 ;;=4^D31.31
 ;;^UTILITY(U,$J,358.3,14233,2)
 ;;=^5002121
 ;;^UTILITY(U,$J,358.3,14234,0)
 ;;=H34.813^^82^775^13
 ;;^UTILITY(U,$J,358.3,14234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14234,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Bilateral
 ;;^UTILITY(U,$J,358.3,14234,1,4,0)
 ;;=4^H34.813
 ;;^UTILITY(U,$J,358.3,14234,2)
 ;;=^5005570
 ;;^UTILITY(U,$J,358.3,14235,0)
 ;;=H34.812^^82^775^14
 ;;^UTILITY(U,$J,358.3,14235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14235,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,14235,1,4,0)
 ;;=4^H34.812
 ;;^UTILITY(U,$J,358.3,14235,2)
 ;;=^5005569
 ;;^UTILITY(U,$J,358.3,14236,0)
 ;;=H34.811^^82^775^15
 ;;^UTILITY(U,$J,358.3,14236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14236,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,14236,1,4,0)
 ;;=4^H34.811
 ;;^UTILITY(U,$J,358.3,14236,2)
 ;;=^5005568
 ;;^UTILITY(U,$J,358.3,14237,0)
 ;;=E11.321^^82^775^66
 ;;^UTILITY(U,$J,358.3,14237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14237,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14237,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,14237,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,14238,0)
 ;;=E11.329^^82^775^67
 ;;^UTILITY(U,$J,358.3,14238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14238,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14238,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,14238,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,14239,0)
 ;;=E11.331^^82^775^68
 ;;^UTILITY(U,$J,358.3,14239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14239,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14239,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,14239,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,14240,0)
 ;;=E11.339^^82^775^69
 ;;^UTILITY(U,$J,358.3,14240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14240,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14240,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,14240,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,14241,0)
 ;;=E11.351^^82^775^70
